A Clinical Comparison of Marketed Lens Care Solutions With Avaira Lens Brand

Exclusion Criteria

• •History of hypersensitivity
• •Evidence or history of epithelial herpes simplex keratitis (dendritic keratitis; vaccinia, active or recent varicella, viral disease of the cornea and/or conjunctiva and/or eyelids; bacterial infection of the eye; and/or fungal disease of the eye
• •One functional eye or a monofit eye
• •Ocular conditions such as active acute blepharitis, conjunctival infections, and iritis
• •Type 2 (macropunctate) or greater corneal staining in any region in either eye as observed by slit-lamp at Visit 1 of each study period
• •Sum of the type of corneal staining greater than or equal to 4 across entire cornea in either eye as observed by slit-lamp at Visit 1 of each study period
• •Conjunctival staining covering greater than or equal to 20% in 2 or more corneal regions in either eye as observed by slit-lamp at Visit 1 of each study period
• •Conjunctival injection greater than Grade 2 (moderate-diffuse redness) in either eye as observed by slit-lamp at Visit 1 of each study period
• •Abnormal lenticular opacity in the visual axis of the lens in either eye
• •Use of concomitant topical Rx or over-the-counter (OTC) ocular medications
• •History of seasonal allergies with significant ocular side effects which may have an adverse impact on contact lens wear
• •Pregnant or lactating females